Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study.
暂无分享,去创建一个
Hans Raabe | Manfred Liebsch | Maurice Whelan | Thomas Cole | Agnieszka Kinsner-Ovaskainen | Rodger Curren | A. Kinsner-Ovaskainen | M. Whelan | R. Gibson | R. Curren | P. Prieto | M. Liebsch | Pilar Prieto | Rosemary M Gibson | Anita M Tuomainen | H. Raabe | Thomas Cole | Anita M. Tuomainen
[1] Michael Balls,et al. Acute Toxicity Testing in Vitro and the Classification and Labelling of Chemicals , 1996 .
[2] Valérie Zuang,et al. A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.
[3] Markus Schulz,et al. Refinement and Reduction of Acute Oral Toxicity Testing: A Critical Review of the Use of Cytotoxicity Data , 2011, Alternatives to laboratory animals : ATLA.
[4] Troy Seidle,et al. Examining the regulatory value of multi-route mammalian acute systemic toxicity studies. , 2011, ALTEX.
[5] Sebastian Hoffmann,et al. Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Helmut Segner,et al. MEIC Evaluation of Acute Systemic Toxicity , 1998 .
[7] P. van Bladeren,et al. The liver, kidney, and thyroid toxicity of chlorinated benzenes. , 1991, Toxicology and applied pharmacology.
[8] Ian Indans,et al. Acute toxicity testing of chemicals—Opportunities to avoid redundant testing and use alternative approaches , 2010, Critical reviews in toxicology.
[9] Sally Robinson,et al. A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development. , 2008, Regulatory toxicology and pharmacology : RTP.
[10] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[11] W. Stokes,et al. Neutral Red Uptake Cytotoxicity Tests for Estimating Starting Doses for Acute Oral Toxicity Tests , 2008, Current protocols in toxicology.
[12] Sally Robinson,et al. Cross-Sector Review of Drivers and Available 3Rs Approaches for Acute Systemic Toxicity Testing , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[13] V Rogiers,et al. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science. , 2010, Toxicology and applied pharmacology.
[14] Sebastian Hoffmann,et al. Estimation of acute oral toxicity using the No Observed Adverse Effect Level (NOAEL) from the 28 day repeated dose toxicity studies in rats. , 2009, Regulatory toxicology and pharmacology : RTP.
[15] Horst Spielmann,et al. Determination of the Starting dose for Acute Oral Toxicity (LD50) Testing in the up and down Procedure (UDP) from Cytotoxicity Data , 1999, Alternatives to laboratory animals : ATLA.
[16] Sandra Coecke,et al. Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[17] Valérie Zuang,et al. The ECVAM International Validation Study on In Vitro Tests for Acute Skin Irritation: Selection of Test Chemicals , 2007, Alternatives to laboratory animals : ATLA.
[18] Q. Chaudhry,et al. Scientific Committee on Consumer Safety SCCS , 2010 .
[19] M. Sjöström,et al. MEIC evaluation of acute systemic toxicity : Part VIII. Multivariate partial least squares evaluation, including the selection of a battery of cell line tests with a good prediction of human acute lethal peak blood concentrations for 50 chemicals , 2000 .
[20] W. Halle. Toxizitätsprüfungen in Zellkulturen für eine Vorhersage der akuten Toxizität (LD50) zur Einsparung von Tierversuchen , 1998 .